Cargando…
STING expression and response to treatment with STING ligands in premalignant and malignant disease
Human papilloma virus positive (HPV(+)) tumors represent a large proportion of anal, vulvar, vaginal, cervical and head and neck squamous carcinomas (HNSCC) and late stage invasive disease is thought to originate from a premalignant state. Cyclic dinucleotides that activate STimulator of INterferon...
Autores principales: | Baird, Jason R., Feng, Zipeng, Xiao, Hong D., Friedman, David, Cottam, Ben, Fox, Bernard A., Kramer, Gwen, Leidner, Rom S., Bell, R. Bryan, Young, Kristina H., Crittenden, Marka R., Gough, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685615/ https://www.ncbi.nlm.nih.gov/pubmed/29135982 http://dx.doi.org/10.1371/journal.pone.0187532 |
Ejemplares similares
-
Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2018) -
Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy
por: Baird, Jason, et al.
Publicado: (2015) -
Intratumoral injection of STING ligand promotes abscopal effect
por: Baird, Jason R, et al.
Publicado: (2014) -
A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021) -
Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
por: Zebertavage, Lauren K., et al.
Publicado: (2020)